Indications and uses
How to Use: After using lotion, apply an appropriate amount to the entire face, and gently pat to enhance absorption.
How to Use: After using lotion, apply an appropriate amount to the entire face, and gently pat to enhance absorption.
How to Use: After using lotion, apply an appropriate amount to the entire face, and gently pat to enhance absorption.
Active Ingredients: DIMETHICONE 1%, ALLANTOIN 0.5%
Inactive Ingredients:
BAMBUSA VULGARIS WATER, CYCLOPENTASILOXANE, BUTYLENE GLYCOL, CYCLOMETHICONE, SQUALANE, BETAINE, PENTYLENE GLYCOL, SILICA, POLYSORBATE 20, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, AMARANTHUS CAUDATUS SEED EXTRACT, ULMUS DAVIDIANA ROOT EXTRACT, AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER, PIPER METHYSTICUM LEAF/ROOT/STEM EXTRACT, XANTHAN GUM, FRAGRANCE, SORBITAN SESQUIOLEATE, ARCTIUM LAPPA ROOT EXTRACT, POLYSORBATE 60, PHENOXYETHANOL, SEA WATER, BAMBUSA VULGARIS CALLUS CULTURE EXTRACT, ALOE BARBADENSIS LEAF EXTRACT, HIBISCUS ESCULENTUS FRUIT EXTRACT, LINUM USITATISSIMUM (LINSEED) SEED EXTRACT, BAMBUSA VULGARIS EXTRACT, PORTULACA OLERACEA EXTRACT, PUERARIA THUNBERGIANA ROOT EXTRACT, CNIDIUM OFFICINALE ROOT EXTRACT, GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT, PAEONIA LACTIFLORA ROOT EXTRACT, ETHYLHEXYLGLYCERIN, BIFIDA FERMENT LYSATE, SOLUBLE COLLAGEN, WATER, ALOE BARBADENSIS LEAF JUICE, SODIUM HYALURONATE, DISODIUM EDTA, HYDROGENATED LECITHIN, 1,2-HEXANEDIOL, CAPRYLYL GLYCOL, TROPOLONE
Purpose: Highly moisturizing hydrant essence with the added bamboo water.
Cautions:
For external use only.
Avoid contact with eyes and mouth.
Discontinue use if signs of irritation or rash appear.
Keep out of reach of children.
Replace the cap after use.
KEEP OUT OF REACH OF CHILDREN
How to Use: After using lotion, apply an appropriate amount to the entire face, and gently pat to enhance absorption.
How to Use: After using lotion, apply an appropriate amount to the entire face, and gently pat to enhance absorption.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51346-123-01 | 2021-07-14 | C162847 | 48780-1 | 9d75b9d0-5bab-f424-e053-dadaa90a57ce | 83cc53b9-1f49-44d5-9b7a-9bb740592c7a |
| 51346-123-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5bab-f424-e053-dadaa90a57ce | 83cc53b9-1f49-44d5-9b7a-9bb740592c7a |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALLANTOIN | ACTIVE INGREDIENT | 344S277G0Z | 1 | |
| DIMETHICONE | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ALLANTOIN | ACTIVE MOIETY | 344S277G0Z | 1 | |
| DIMETHICONE | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| BETAINE | INACTIVE INGREDIENT | 3SCV180C9W | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| PENTYLENE GLYCOL | INACTIVE INGREDIENT | 50C1307PZG | 1 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51346-123 | 51346-123-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | ACTIM |
| ALLANTOIN | 344S277G0Z | ACTIM |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| CYCLOMETHICONE | NMQ347994Z | IACT |
| SQUALANE | GW89575KF9 | IACT |
| BETAINE | 3SCV180C9W | IACT |
| PENTYLENE GLYCOL | 50C1307PZG | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SQUALANE | SQUALANE | GW89575KF9 | AEROSOL, FOAM / TOPICAL | 2.23 %w/w | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 389 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v | ||
| SQUALANE | SQUALANE | GW89575KF9 | SOLUTION / TOPICAL | 1 %w/w | ||
| SQUALANE | SQUALANE | GW89575KF9 | POWDER / ORAL | 0.02 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | AEROSOL, FOAM / TOPICAL | 376 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | CREAM, AUGMENTED / TOPICAL | 120 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 358 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | CREAM / TOPICAL | 6 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9c48da47-0662-4f75-84d8-7a2c87455a27 | 83cc53b9-1f49-44d5-9b7a-9bb740592c7a | 2021-07-13 | Warnings | 83cc53b9-1f49-44d5-9b7a-9bb740592c7a |
Adverse event summaries are temporarily unavailable. Other product information remains available.